Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Journal of Medicinal Chemistry|October 17, 2022
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary AngioedemaRebecca L Davie, Hannah J Edwards, D Michael Evans, et al.
BMC Nephrology|November 10, 2016
Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility studyAlex R Chang, Michael Evans, Christina Yule, et al.
Frontiers in Nutrition|June 29, 2023
Clinical trial of a probiotic and herbal supplement for lung healthNancy M Wenger, Luhua Qiao, Teodora Nicola, et al.
F1000Research|November 13, 2018
Publishing peer review materialsJeffrey Beck, Kathryn Funk, Melissa Harrison, et al.
Pulmonary Therapy|November 18, 2025
Double-Blind Randomized Placebo-Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary DiseaseTeodora Nicola, Nancy M Wenger, Kara Seidman, et al.
Transfusion|December 12, 2025
D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative StudyFatima A Aldarweesh, Rim Abdallah, Ingrid Perez Alvarez, et al.
Oncology|August 30, 2017
Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare TumorMichael Evans, Yuan Liu, Chuqing Chen, et al.
The Lancet. Oncology|November 3, 2023
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trialRahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
JAMA Psychiatry|October 10, 2019
Comparison of the Association Between Goal-Directed Planning and Self-reported Compulsivity vs Obsessive-Compulsive Disorder DiagnosisClaire M Gillan, Eyal Kalanthroff, Michael Evans, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2010
The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradationIgor Vivanco, Daniel Rohle, Matthias Versele, et al.
Pageof 18